Market
Mark Cuban Upgrades TrumpRx to 'A-' — 'They're Doing A Good Job Actually' Says Denting Big Insurance Conglomerates Is A 'Win'
Mark Cuban isn't grading for style points—he's grading for impact. The billionaire co-founder of Cost Plus Drugs revisited TrumpRx and made clear what matters most: if it pressures the right players, it's working. From "B" To ‘A-' — Why The...
Was this article helpful?
Community
Loading comments...
